Case details

Court: ded
Docket #: 1:17-cv-01631
Case Name: AbbVie Inc. et al v. Cipla Limited et al
PACER case #: 63702
Date filed: 2017-11-10
Assigned to: Judge Richard G. Andrews
Case Cause: 35:271 Patent Infringement
Nature of Suit: 835 Patent - Abbreviated New Drug Application(ANDA)
Jury Demand: None
Jurisdiction: Federal Question

Parties

Represented Party Attorney & Contact Info
AbbVie Inc.
Plaintiff
 
Mary B. Graham
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street
P.O. Box 1347
Wilmington, DE 19899
(302) 658-9200
Email: mbgefiling@mnat.com
LEAD ATTORNEY
ATTORNEY TO BE NOTICED

Derek James Fahnestock
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street
P.O. Box 1347
Wilmington, DE 19899
302-658-9200
Email: dfahnestock@mnat.com
ATTORNEY TO BE NOTICED
AbbVie Deutschland GmbH & Co. KG
Plaintiff
 
Mary B. Graham
(See above for address)
LEAD ATTORNEY
ATTORNEY TO BE NOTICED

Derek James Fahnestock
(See above for address)
ATTORNEY TO BE NOTICED
Cipla Limited
Defendant
Cipla USA Inc.
Defendant

Documents

Date Filed Document # Attachment # Short Description Long Description Upload date SHA1 hash
2017-11-10 1 0 COMPLAINT FOR PATENT INFRINGEMENT filed against Cipla Limited, Cipla USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2264214.) - filed by AbbVie Inc., AbbVie Deutschland GmbH & Co. KG. (Attachments: # 1 Exhibits A-I, # 2 Civil Cover Sheet)(nmfn) (Entered: 11/13/2017) 2017-11-17 00:51:06 7fc06e3b70e7822baecfb558bc610abb26f134b1
1 1 Exhibits A-I
1 2 Civil Cover Sheet
2017-11-10 2 0 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmfn) (Entered: 11/13/2017)
2017-11-10 3 0 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 9/27/2017. Date of Expiration of '359 Patent: 7/19/2019. Pediatric exclusivity ('359 Patent): 1/19/2020. Thirty Month Stay Deadline: 3/27/2020. SEE ANDA FORM for the expiration date of the remaining 8 patents as well as the pediatric exclusivity deadlines for the remaining 8 patents. (nmfn) (Entered: 11/13/2017)
2017-11-10 4 0 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,148,359; 7,364,752; 8,025,899; 8,268,349; 8,309,613; 8,377,952; 8,399,015; 8,470,347; 8,691,878. (nmfn) (Entered: 11/13/2017)